Endomyocardial biopsy in patients with myocarditis—still justified in the CMR era? A single-centre experience
Open Access
- 21 November 2024
- journal article
- research article
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 115 (5) , 743-751
Abstract
Background: In the past decades, cardiovascular magnetic resonance (CMR) was established as a non-invasive tool supporting the diagnosis of myocarditis and there is often reluctance in performing EMB due to potentially severe complications. We sought to identify patient subgroups that could still benefit from EMB in the CMR era. Methods: Data of patients presenting with myocarditis between 01/2016 and 06/2023 were analysed according to patient risks. Prespecified risk factors were (i) left ventricular ejection fraction (LVEF) ≤ 30%; (ii) severe arrhythmias; or (iii) pre-existing autoimmune disease. Furthermore, the subgroup of recurrent myocarditis cases was analysed separately. Results: A total of 137 patients (35.5 ± 14.8 years, 80.3% male) were included. 26/137 patients had a documented LVEF ≤ 30%, 13/137 a LVEF > 30% with at least one other risk factor and 98/137 a LVEF > 30% without risk factors. EMB was performed in 21/26 patients with LVEF ≤ 30% (80.8%), in 7/13 patients with LVEF > 30% and risk factors (53.8%) and in 16/98 (16%) patients without risk factors. EMB led to the initiation of immunosuppressive therapy in 11/28 patients with risk factors (39.3%) and in none of the patients without risk factors (0/16, 0%, p = 0.003). With respect to the subgroup of patients presenting with recurrent myocarditis ( n = 10), no specific therapy was initiated. Conclusions: Due to a high therapeutic yield for initiation of immunosuppressive therapy in non-infectious myocarditis, performing EMB should be considered in all high-risk patients. In patients without clinical risk factors including cases of recurrent or relapsing myocarditis no specific therapy was initiated.Keywords
Funding Information
- Universitätsklinikum Köln
This publication has 25 references indexed in Scilit:
- Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute MyocarditisCirculation, 2018
- Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional ExperienceThe Annals of Thoracic Surgery, 2016
- Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditisEuropean Heart Journal - Cardiovascular Imaging, 2015
- Hospital Volume and Cardiac Complications of Endomyocardial Biopsy: A Retrospective Cohort Study of 9508 Adult Patients Using a Nationwide Inpatient Database in JapanClinical Cardiology, 2015
- Gradient Spin Echo (GraSE) imaging for fast myocardial T2 mappingJournal of Cardiovascular Magnetic Resonance, 2015
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2013
- Evaluation of the Role of Endomyocardial Biopsy in 851 Patients With Unexplained Heart Failure From 2000–2009Circulation: Heart Failure, 2013
- Comparative Evaluation of Left and Right Ventricular Endomyocardial BiopsyCirculation, 2010
- Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heartMagnetic Resonance in Medicine, 2004
- Idiopathic Giant-Cell Myocarditis — Natural History and TreatmentNew England Journal of Medicine, 1997